Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 5, 2025Neuro-Oncology

Ep18.01 Global Collaboration to Support the Translation of Brain Tumour Therapies: Early Impact and Learnings From a Novel Therapeutics Accelerator.

View Full Paper
Ask AI
Bookmark
Share

Authors

CACharlotte AitkenKBK. BushbyCGCamille Goetz

Discussion

Loading...

Member takes

Overview

A new therapeutics accelerator improves clinical trial design and multidisciplinary input for brain tumour therapies.

Key Points

  • The BTR-NTA has received 29 requests for support from global researchers developing new brain tumour therapies.
  • Eleven therapies have undergone comprehensive review, supported by 37 multidisciplinary experts providing input.
  • Participants reported a 100% intention to refine research and development strategies based on BTR-NTA guidance.
  • The programme highlights recurring translational challenges to assist the broader neuro-oncology community.

Cite This Study

Aitken et al. (2025) studied this question.

synapsesocial.com/papers/68e24e6bd6d66a53c2473acchttps://doi.org/10.1093/neuonc/noaf193.648
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AN INTERNATIONAL NOVEL THERAPEUTICS ACCELERATOR FOR BRAIN TUMOURS: EARLY IMPACT AND LESSONS LEARNED2025
  2. 2BRAIN TUMOUR RESEARCH AND CLINICAL TRIALS ACTIVITY IN THE UK 2016-2024: INSIGHTS FROM THE TESSA JOWELL CENTRE OF EXCELLENCE PROGRAMME2025
  3. 3TRANSFORMING MOLECULAR NEUROPATHOLOGY FOR BRAIN TUMOUR PATIENTS IN THE UK: LESSONS FROM THE TESSA JOWELL CENTRE OF EXCELLENCE PROGRAMME2025
  4. 4Challenges and Innovations in Paediatric Brain Tumour Treatments2025 · 2 citations
  5. 5P05.19.A CLINICAL OUTCOME OF BIOMARKER-GUIDED THERAPIES IN ADULT NEURO-ONCOLOGY PATIENTS: AN UPDATE FROM THE TÜBINGEN MOLECULAR TUMOR BOARD COHORT2025